KOSDAQ - Delayed Quote KRW
MedPacto, Inc. (235980.KQ)
3,165.00
-20.00
(-0.63%)
At close: May 2 at 3:30:30 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
21,806,861.79
21,806,861.79
28,752,088.54
37,193,012.18
29,459,122.29
Operating Income
-21,806,861.79
-21,806,861.79
-28,752,088.54
-37,193,012.18
-29,459,122.29
Net Non Operating Interest Income Expense
1,595,003.47
1,595,003.47
-6,704,997.64
-8,296,637.32
-7,105,797.53
Pretax Income
-20,140,350.64
-20,140,350.64
-35,324,785.77
-35,753,227.22
-17,039,774.05
Net Income Common Stockholders
-20,140,350.64
-20,140,350.64
-35,324,785.77
-35,753,227.22
-17,039,774.05
Basic EPS
-598.00
--
-1.67k
-917.86
-710.38
Diluted EPS
-598.00
--
-1.67k
-917.86
-710.38
Basic Average Shares
33,679.52
--
21,216.09
24,559.72
23,986.84
Diluted Average Shares
33,679.52
--
21,216.09
24,559.72
23,986.84
Total Operating Income as Reported
-21,815,962.05
-21,815,962.05
-28,757,985.75
-37,193,012.23
-29,459,122.35
Rent Expense Supplemental
13,910.33
13,910.33
15,093.77
36,400.95
19,375.10
Total Expenses
21,806,861.79
21,806,861.79
28,752,088.54
37,193,012.18
29,459,122.29
Net Income from Continuing & Discontinued Operation
-20,140,350.64
-20,140,350.64
-35,324,785.77
-35,753,227.22
-17,039,774.05
Normalized Income
-20,695,061.49
-20,695,061.49
-35,669,362.65
-45,865,911.89
-36,721,988.33
Interest Income
1,686,942.70
1,686,942.70
388,458.47
1,323,930.36
663,517.99
Interest Expense
91,939.23
91,939.23
493,225.61
9,620,567.69
7,769,315.54
Net Interest Income
1,595,003.47
1,595,003.47
-6,704,997.64
-8,296,637.32
-7,105,797.53
EBIT
-20,048,411.41
-20,048,411.41
-34,831,560.16
-26,132,659.53
-9,270,458.51
EBITDA
-18,506,643.99
-18,506,643.99
-32,998,893.86
-24,266,406.20
-7,547,098.82
Reconciled Depreciation
1,541,767.42
1,541,767.42
1,832,666.30
1,866,253.33
1,723,359.69
Net Income from Continuing Operation Net Minority Interest
-20,140,350.64
-20,140,350.64
-35,324,785.77
-35,753,227.22
-17,039,774.05
Total Unusual Items Excluding Goodwill
554,710.85
554,710.85
344,576.88
10,112,684.67
19,682,214.28
Total Unusual Items
554,710.85
554,710.85
344,576.88
10,112,684.67
19,682,214.28
Normalized EBITDA
-19,061,354.84
-19,061,354.84
-33,343,470.74
-34,379,090.87
-27,229,313.10
12/31/2021 - 12/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade